Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

LISTEN

Watch

on air now

Create a 6PR account today!

You can now log in once to listen live, watch live, join competitions, enjoy exclusive 6PR content and other benefits.

Joining is free and easy.

You will soon need to register to keep streaming 6PR online. Register an account or skip for now to do it later.

Find out more about registration.

Home
News
Clarity Pharmaceuticals: From $1 to $9 a..

Clarity Pharmaceuticals: From $1 to $9 a share – Could this eventually be a cure for prostate cancer?

23/10/2024

Share this article

BULLS N' BEARS

Business Featured Public Companies

Article image for Clarity Pharmaceuticals: From $1 to $9 a share – Could this eventually be a cure for prostate cancer?

Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals.

BULLS N' BEARS

Business News

Share this article

6PR - Perth's Best Talk Station

Create a 6PR account today!

Joining is free and easy.

Clarity Pharmaceuticals: From $1 to $9 a share – Could this eventually be a cure for prostate cancer?

QUICK LINKS

NEWS

Join the conversation

6PR - Perth's Best Talk Station

Clarity Pharmaceuticals: From $1 to $9 a share – Could this eventually be a cure for prostate cancer?

Cookie and privacy notice